about
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr ...
Read More
3.24
0.06
(1.89%)
531.3K
XNAS Volume
XNAS 22 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Pulmonx Corp is on 31 Jul 2025 for the purpose of Pulmonx Corp Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Pulmonx Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..